An opioid is a class of drugs found in the opium poppy plant and works in the brain to produce a variety of effects, as a relief of pain with many of these drugs. Opioids drugs can be prescription medications regularly referred to as painkillers, and heroin. Opioids drugs are used to block pain signals between the brain and body and are naturally prescribed to treat moderate to severe pain. Also, controlling pain, opioids can make some people feel relaxed, happy, or high, and can be addictive. Additional side effects can include constipation, slowed breathing, nausea, confusion, and drowsiness. The most commonly used opioids are prescription opioids, such as Vicodin, OxyContin, and fentanyl, a synthetic opioid 50–100 times more potent than heroin, morphine, an illegal drug. Global Opioids Drug Market іѕ ѕеgmеntеd on the bаѕіѕ оf Product type (Buprenorphine, Fentanyl, Hydrocodone, Morphine, Oxycodone, Tramadol, and Other Products) Application (Pain Management, Diarrhea Treatment, and Cough Treatment), and region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa). The Global Opioids Drug Market wаѕ vаluеd аt UЅ$ 32,456.2 Мn іn 2020 іѕ рrојесtеd tо іnсrеаѕе ѕіgnіfісаntlу аt а САGR оf 2.6% frоm 2021 tо 2030. The report on Global Opioids Drug Market which оffеrѕ іn-dерth аnаlуѕіѕ оn mаrkеt drіvеrѕ, rеѕtrаіntѕ, орроrtunіtіеѕ, trеndѕ, and other important information regarding the Global Opioids Drug Market. This rероrt іnсludеs quаlіtаtіvе іnfоrmаtіоn and quаntіtаtіvе аnаlуѕіѕ оf vаrіоuѕ ѕеgmеntѕ іn tеrmѕ оf mаrkеt ѕhаrе, grоwth, орроrtunіtу аnаlуѕіѕ, mаrkеt value, еtс. fоr thе fоrесаѕt уеаrѕ. The report offers detailed information regarding the various key players operating in the Global Opioids Drug Market, their financials, key developments, supply chain trends, technological innovations, apart from future strategies, acquisitions & mergers, market footprint, and COVID-19 Analysis. This report is based on analysis, synthesis, and interpretation of the information gathered regarding the Global Opioids Drug Market from various sources. We analyzed the data and information and gained insights using primary and secondary research efforts with the primary objective to provide a holistic view of the Global Opioids Drug Market. Market Dynamics: Increasing demand for opioids drugs due to the rising incidence of chronic health conditions such as heart disease, cancer, stroke, type 2 diabetes, obesity is a key factor expected to drive the growth of the global market during the forecast period. The increasing number of generic approvals by health authorities of several countries is another factor contributing to the growth of the global opioids drugs market. However, stringent government rules and regulations on the prescription of opioids drugs are major factors restraining the growth of the global opioids drug market. Segmental Analysis: Among the product type segments, the oxycodone segment is accounted for a major revenue share and is expected to dominate the global opioids drug market, due to increasing consumption for pain management. The fentanyl segment is expected to the fastest growth of the global opioids drug market, owing to its availability in several formulations includes a nasal spray for treating chronic pain, transdermal patches, oral tablets & lozenges, and solution for injection in multiple concentration for pain management and anesthesia. Among the application segments, the pain management segment is expected to dominate the global market, due to high usage in pain management therapies. Regional Analysis: North America opioids drug market dominates the global market in terms of revenue contribution as compared to that of markets in other regions, due to the presence of leading manufacturers and increasing incidence of chronic diseases in the countries in the region. Europe market is accounted for the second-largest revenue share contribution in the global opioids drugs market, followed by markets in the Asia Pacific, Latin America, and the Middle East & Africa respectively. The Asia Pacific market is projected to register comparatively faster growth in terms of revenue over the next 10 years, owing to the increasing prevalence of cancer and orthopedic disease. Global Opioids Drug Market Segmentation:
Segmentation by Product Type: • Buprenorphine • Fentanyl • Hydrocodone • Morphine • Oxycodone • Tramadol • Others Segmentation by Application: • Pain Management o Neuropathic Pain o Migraine o Back Pain o Osteoarthritis Pain o Cancer Pain o Others • Diarrhea Treatment • Cough Treatment Segmentation by region: North America Europe Asia Pacific Latin America Middle East & Africa
Key Players:
Pfizer Inc. Boehringer Ingelheim Janssen Pharmaceuticals, Inc. Sanofi S.A. Allergan, Plc GlaxoSmithKline Teva Pharmaceutical Industries Ltd. Sun Pharmaceuticals Mallinckrodt Pharmaceuticals Endo Pharmaceuticals Inc.
Scope:
Report Data
Market
Forecast 2022
XX million/billion (2022-2032)
CAGR 2022 - 2032
%
Analysis Period
2022 - 2032
Base Year
2021
Forecast Data
2022 - 2032
Segments Covered
By Type, By Application, And by Regions
Regional Scope
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
1 Introduction (Page No. - 15) 1.1 The objectives of this study 1.2 Market Definition 1.2.1 Market Scope 1.3 Research Methodology 1.4 Stakeholders 1.5 Currency 1.6 Research Assumptions 1.7 Limitation 2 Executive Summary (Page No. - 25)
3. Market Outlook (Page No. - 29) 3.1 Introduction 3.2 DROC Matrix 3.3 Market Challenges 3.4 Market Share Analysis 3.5 Value chain Analysis 3.6 COVID-19 Impacts on Global Opioids Drug Industry
4 Industry Trends (Page No. - 42) 4.1 Introduction 4.2 PESTEL Analysis 4.3 Porter’s Five Forces Model 4.3.1 Threat of new entrance 4.3.2 Threat of substitute product 4.3.3 Bargaining power of buyer 4.3.4 Bargaining power of supplier 4.3.5 Intensity of competitive rivalry
6 Opioids Drug Market Shopper Type Analysis (Page No. - 60) 6.1 Introduction 6.2 Benchmark Market Revenue Analysis by Shopper Type, 2015-2019 6.3 Estimated and Projected Market Analysis by Shopper Type, 2020-2030 6.4 Y-o-Y Growth Trend Analysis 6.5 Pain Management 6.5.1 Neuropathic Pain 6.5.2 Migraine 6.5.3 Back Pain 6.5.4 Osteoarthritis Pain 6.5.5 Cancer Pain 6.5.6 Others 6.6 Diarrhea Treatment 6.7 Cough Treatment
7 Opioids Drug Regional Analysis (Page No. – 67) 7.1 Introduction 7.2 North America 7.2.1 Benchmark Market Revenue Analysis by Country, 2015-2019 7.2.2 Estimated and Projected Market Analysis by Country, 2020-2030 7.2.3 U.S. 7.2.4 Canada 7.2.5 Mexico 7.3 Europe 7.3.1 Benchmark Market Revenue Analysis by Country, 2015-2019 7.3.2 Estimated and Projected Market Analysis by Country, 2020-2030 7.3.3 U.K. 7.3.4 Germany 7.3.5 France 7.3.6 Rest of Europe 7.4 Asia-Pacific (APAC) 7.4.1 Benchmark Market Revenue Analysis by Country, 2015-2019 7.4.2 Estimated and Projected Market Analysis by Country, 2020-2030 7.4.3 Japan 7.4.4 China 7.4.5 India 7.4.6 Rest of APAC 7.5 Rest of the World (RoW) 7.5.1 Benchmark Market Revenue Analysis by Country, 2015-2019 7.5.2 Estimated and Projected Market Analysis by Country, 2020-2030 7.5.3 Middle East 7.5.4 Africa 7.5.5 Latin America
8 Company Profiles (Page No. - 87) (Overview, Products & Services, Strategies & Insights, recent Developments)* 8.1 Pfizer Inc. 8.2 Boehringer Ingelheim 8.3 Janssen Pharmaceuticals, Inc. 8.4 Sanofi S.A. 8.5 Allergan, Plc 8.6 GlaxoSmithKline 8.7 Teva Pharmaceutical Industries Ltd. 8.8 Sun Pharmaceuticals 8.9 Mallinckrodt Pharmaceuticals 8.10 Endo Pharmaceuticals Inc. TABLE 1 WORLD OPIOIDS DRUG ESTIMATED AND PROJECTED REGIONAL ANALYSIS, 2020-2030 (USD MILLION) TABLE 2 WORLD OPIOIDS DRUG BENCHMARK MARKET REVENUE ANALYSIS BY CATEGORY, 2015-2019, (USD MILLION) TABLE 3 WORLD OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030 (USD MILLION) TABLE 4 WORLD OPIOIDS DRUG BENCHMARK MARKET REVENUE ANALYSIS BY SHOPPER TYPE, 2015-2019, (USD MILLION) TABLE 5 WORLD OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030 (USD MILLION) TABLE 6 NORTH AMERICA WORLD OPIOIDS DRUG BENCHMARK MARKET REVENUE ANALYSIS BY COUNTRY, 2015-2019, (USD MILLION) TABLE 7 NORTH AMERICA OPIOIDS DRUG ESTIMATED AND PROJECTED COUNTRY ANALYSIS, 2020-2030 (USD MILLION) TABLE 8 NORTH AMERICA OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030 (USD MILLION) TABLE 9 NORTH AMERICA OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030 (USD MILLION) TABLE 10 U.S. OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030 (USD MILLION) TABLE 11 U.S. OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030 (USD MILLION) TABLE 12 CANADA OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030 (USD MILLION) TABLE 13 CANADA OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030 (USD MILLION) TABLE 14 MEXICO OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030 (USD MILLION) TABLE 15 CANADA OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030 (USD MILLION) TABLE 16 EUROPE WORLD OPIOIDS DRUG BENCHMARK MARKET REVENUE ANALYSIS BY COUNTRY, 2015-2019, (USD MILLION) TABLE 17 EUROPE OPIOIDS DRUG ESTIMATED AND PROJECTED COUNTRY ANALYSIS, 2020-2030 (USD MILLION) TABLE 18 EUROPE OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030 (USD MILLION) TABLE 19 EUROPE OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030 (USD MILLION) TABLE 20 U.K. OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030 (USD MILLION) TABLE 21 U.K. OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030 (USD MILLION) TABLE 22 GERMANY OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030 (USD MILLION) TABLE 23 GERMANY OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030 (USD MILLION) TABLE 24 FRANCE OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030 (USD MILLION) TABLE 25 FRANCE OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030 (USD MILLION) TABLE 26 REST OF EUROPE OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030 (USD MILLION) TABLE 27 REEST OF EUROPE OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030 (USD MILLION) TABLE 28 ASIA-PACIFIC WORLD OPIOIDS DRUG BENCHMARK MARKET REVENUE ANALYSIS BY COUNTRY, 2015-2019, (USD MILLION) TABLE 29 ASIA-PACIFIC OPIOIDS DRUG ESTIMATED AND PROJECTED COUNTRY ANALYSIS, 2020-2030 (USD MILLION) TABLE 30 ASIA-PACIFIC OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030 (USD MILLION) TABLE 31 ASIA-PACIFIC OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030 (USD MILLION) TABLE 32 JAPAN OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030 (USD MILLION) TABLE 33 JAPAN OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030 (USD MILLION) TABLE 34 CHINA OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030 (USD MILLION) TABLE 35 CHINA OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030 (USD MILLION) TABLE 36 INDIA OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030 (USD MILLION) TABLE 37 INDIA OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030 (USD MILLION) TABLE 38 REST OF APAC OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030 (USD MILLION) TABLE 39 REST OF APAC OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030 (USD MILLION) TABLE 40 ROW OPIOIDS DRUG BENCHMARK MARKET REVENUE ANALYSIS BY COUNTRY, 2015-2019, (USD MILLION) TABLE 41 ROW OPIOIDS DRUG ESTIMATED AND PROJECTED COUNTRY ANALYSIS, 2020-2030 (USD MILLION) TABLE 42 ROW OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030 (USD MILLION) TABLE 43 ROW OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030 (USD MILLION) TABLE 44 MIDDLE EAST OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030 (USD MILLION) TABLE 45 MIDDLE EAST OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030 (USD MILLION) TABLE 46 AFRCA OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030 (USD MILLION) TABLE 47 AFRICA OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030 (USD MILLION) TABLE 48 LATIN AMERICA OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030 (USD MILLION) TABLE 49 LATIN AMERICA OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030 (USD MILLION)
Frequently Asked Questions
What is the future market value of the ?
The current market value for is expected USD XX million/billion by 2022.
What is the CAGR of the Market?
The is to grow at a CAGR of 5.3% during the forecast by 2032.
What is the Market segment?
On the basis of type, the is segmented into Types.